Merck No Longer in Talks to Buy Revolution Medicines

Date:




The drugmaker had recently been in discussions to acquire RevMed in a deal that could have valued the cancer-drug biotech at around $30 billion.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Delta Delays Hundreds of Flights Over System Outage

The issues have arisen a little more than week...

2026 women’s basketball Feast Week games: Schedule, analysis

Charlie CremeNov 21, 2026, 07:40 PM ETCloseCharlie Creme projects...

Española Oñate Bridge without lighting due to repeat wire thieves

ESPAÑOLA, N.M. (KRQE) – It's a prominent bridge in...